Predictive Oncology completes $344 million private placement transaction to launch Aethir (ATH) treasury strategy

Foresight News, Predictive Oncology Inc. announced that the company announced two private placement transactions today, planning to raise about $344 million to support its digital asset treasury strategy, mainly holding native utility tokens for the Aethir (ATH) ecosystem.

The transaction overview shows that the company will raise approximately $344.4 million through private equity investments (PIPEs) in public transactions, including approximately 66.7 million shares of common stock (or advance warrants to purchase common stock) at a price of $0.7751 per share, with an estimated cash income of approximately $51.7 million (“Cash PIPE”), and an advance warrant to purchase up to 223.6 million shares of common stock, with a purchase price of $0.01 for each warrant, expected to be exchanged for approximately $292.7 million in nominal value, of which $173.3 million is the discount value, involving locked and unlocked Aethir tokens. The prepaid warrants issued in the cryptographic PIPE will be exercised immediately after the company receives shareholder approval. The PIPE transaction is expected to be completed at the same time around October 2, 2025, and the regular delivery conditions must be met.

The company plans to use ATH's in-kind contribution to support its digital asset treasury strategy and to use the remaining net proceeds from the PIPE transactions primarily to acquire ATH on the open market to further support the strategy, as well as for working capital and general corporate purposes.

Disclaimer: The views in this article only represent the author's personal views and do not constitute investment advice of this platform. This platform does not make any guarantees for the accuracy, completeness, originality and timeliness of article information, nor is it liable for any losses caused by the use or trust in article information.